did not ovulate and showed low secretion of progesterone and oestradiol. Addition of LH + 3-isobutyl-1-methylxanthine resulted in a marked stimulation of steroid release, and ovulations occurred in all ovaries (9.0 \ m=+-\ 0.9; mean \ m=+-\ sem). The protein tyrosine kinase inhibitors, genistein and tyrphostin A25, significantly inhibited ovulation at the higher concentrations tested (3.0 \m=+-\0.3at 100 \g=m\molgenistein l \m=-\1; 5.8 \ m=+-\ 1.0 at 500 \g=m\mol tyrphostin A25 l \ m=-\ 1) but no effect was seen at lower concentrations. The presence of genistein and tyrphostin A25 at any concentration used did not significantly decrease the LH + 3-isobutyl-1-methylxanthine-induced progesterone or oestradiol concentrations. The intraovarian concentrations of plasminogen activator activity, and prostaglandin E2 and F2\ g=a\ were not altered by the presence genistein (100 \g=m\moll \ m=-\ 1) . In conclusion, the results of the present study indicate that protein tyrosine kinase signalling pathways are integral parts of the mammalian ovulatory process but do not involve actions on the synthesis of steroids, plasminogen activator or prostaglandins.
Introduction
Mammalian ovulation involves complex intraovarian mechanisms that are regulated by a number of autocrine and paracrine factors (Brännström et al, 1996) . Binding of LH to its receptor induces the expression of several genes or activates enzyme systems to increase the intrafollicular concentrations of mediators which, in a redundant fashion, control the continued ovulatory process. The LH-induced signal to cause ovulation seems to be transduced primarily by the cAMP-protein kinase A (Brännström et al, 1987a) and phosphoinositol-protein kinase C (Kaufmann et al, 1992) second messenger systems. Several mediators of the growth factor and cytokine families may be of importance in the cascade leading to oocyte meiosis, follicle rupture and luteinization. Several of these mediators are dependent on tyrosine phosphorylation. Among these mediators, epidermal growth factor (EGF) seems to be involved in the stimulation of oocyte meiosis and cumulus cell expansion (Downs, 1989) . Inhibitory effects of EGF on the ovulatory mechanism may also exist, since adrninistration of EGF to the in vitro perfused rabbit ovary results in a significant reduction in ovulatory efficiency (Endo et al, 1992) . EGF possesses intrinsic protein tyrosine kinase (FTK) activity (Smith et al, 1993) and there are several PTK interaction sites on the intracellular domain of the EGF receptor (Seedorf, 1995) .
Platelet-derived growth factor (PDGF) enhances plasminogen activator (PA) activity in granulosa cells but not in theca cells of the ovulating follicle in domestic hens (Tilly and Johnson, 1990) . Another factor of this family, vascular epidermal growth factor (VEGF), may be involved in control of angiogenesis and permeability changes at ovulation (Koos, 1993) .
Inflammatory changes are active in ovulation and several of these processes may be controlled by cytokines (Brännström et al, , 1994 , such as interleukin (IL) 1, IL-6 and granulocyte macrophage colony stimulating factor (GM-CSF). The expression of IL-1 in rat theca interstitial cells is induced by LH (Hurwitz et al, 1991) , and IL-1 induces ovulation in vitro (Brännström et al, 1993b) . Furthermore, a regulatory effect of colony stimulating factor 1 (CSF-1) on rate of ovulation has been indicated (Cohen et al, 1997) . The intracellular signalling pathways for these cytokines are reported to involve activity of non-receptor PTK (Tadagatsu, 1995) , which would lead to enhanced downstream signal transductions (Schaffhausen, 1995) .
The aim of the present study was to investigate the possible role of PTK in the mechanism controlling the ovulatory process by use of genistein, which is a potent noncompetitive inhibitor (Akiyama and Ogawara, 1991) of soluble and membrane-bound PTK (Tadagatsu, 1995) . Genistein is an isoflavone phyto-oestrogen that has both oestrogenic and anti-oestrogenic effects (Wähäle et al, 1995) , as well as other non-specific effects (Grunicke, 1991) . In view of these non-PTK related effects by genistein, a second PTK inhibitor (tyrphostin A25) was also used. A well characterized method involving isolated rat ovaries during in vitro perfusion (Brännström, 1993a) was used to exclude systemic effects of PTK inhibition on the ovulatory process.
Materials and Methods

Chemicals and hormones
Ovine luteinizing hormone 
Perfusion
The procedure and experimental set up is shown schematically (Fig. 1) . The perfusions were performed as described by Koos et al (1984) with minor modifications (Brännström et al, 1987b (Fig. 2) . In the unstimulated control group (n = 6), no ovulation occurred, whereas addition of LH + IBMX (n = 8) resulted in ovulations from all perfused ovaries (9.0 ± 0.9; mean ± sem). Administration of 10 pmol genistein l"1 (n = 6) did not significantly change the LH + IBMXinduced ovulation rate (8.8 ±1.3). The ovulation rate was significantly reduced (P < 0.01) by the administration of a tenfold higher concentration of genistein (3.0 ± 0.3; = 5) and the higher concentration of tyrphostin A25 (5.8 ± 1.0 at 500 pmol ; =4).
Steroid concentrations
The concentrations of progesterone and oestradiol in the perfusion medium, evaluated at five different time points throughout the perfusions are presented (Figs 3 and 4) . (Fig. 3) . Oestradiol concentrations in the control group were significantly lower than they were in the LH + IBMX group at 1, 3 and 8 h (Fig. 4) (Yano et al, 1996) .
Although the half-maximal effects of both genistein and tyrphostin A25 seem to be similar, the present study showed that genistein effectively inhibited ovulation at 100 umol l"1, whereas tyrphostin A25 was ineffective at this concentration. The relatively high concentrations of both PTK inhibitors added to obtain inhibition of ovulation in this specific perfusion system are in accordance with earlier studies in which, in some cases, drugs needed to be present in the micromolar range (Brännström, 1993b (Morioka et al, 1988) but that progesterone was essential (Brännström and Janson, 1988 (Orly et al, 1994) . The inhibition of these steroidogenic enzymes by PTK inhibitors was shown to be less pronounced in granulosa cells of the preovulatory stage and in luteinized granulosa cells (Orly et al, 1996) (Bruning et al, 1981) . In contrast, progesterone is rapidly adsorbed, with a fj of 2.9 h of exogenously added progesterone (Brännström et al, 1987b (Beers et al, 1975) . Plasminogen activator is secreted from the granulosa cells and the PA gene activity is enhanced around the time of the LH surge (Shimamoto et al, 1993) , and growth factors, such as EGF, have been implicated as regulators of PA expression (Galway et al, 1989) . In the present study, the 10 h perfusion showed no significant difference in intraovarian PA concentration when the gonadotrophinstimulated ovaries and those also treated with genistein were compared. These findings indicate that the PTK pathways in the ovulatory process do not involve the PA system.
Exogenously added EGF decreases ovulatory efficiency in the in vitro perfused rabbit ovary (Endo et al, 1992) . This finding is somewhat in contrast to those of the present study, in which a presumed inhibition of EGF-mediated effects by PTK inhibition also resulted in a decreased ovulatory response. This discrepancy may be explained by reported species differences between the rabbit and rat in the regulation of ovulation (Brännström and Janson, 1988) or by an EGF-mediated negative regulation of the ovulatory process in rats that was not detected in the present study, in which it is likely that several important PTK mediated pathways were inhibited.
In conclusion, this study demonstrates that PTK is involved critically in the intraovarian events of follicular rupture but does not influence the luteinization process in terms of progesterone secretion. The action of PTK does not involve the prostaglandin or PA systems.
